Quantcast

Latest Personalized medicine Stories

2014-05-04 08:21:24

GeneSight Psychotropic Expands to Cover 38 FDA-Approved Antidepressant and Antipsychotic Medications MASON, Ohio, May 4, 2014 /PRNewswire/ -- Assurex Health today announced an enhancement of its GeneSight® Psychotropic test, providing clinicians with the most comprehensive genetic-based tool available to help them make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, post-traumatic stress disorder (PTSD), bipolar disorder,...

2014-05-02 12:27:01

MUMBAI, May 2, 2014 /PRNewswire/ -- Bharat Book Bureau presents Global & USA Cancer Biomarker Market to 2018. It is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. https://www.bharatbook.com/medical-devices-market-research-reports-489693 Cancer biomarkers are...

2014-04-30 08:31:39

DUBLIN, Apr. 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wzl2nj/tissue) has announced the addition of the "Tissue Diagnostics Market by Technology, Disease, Product, End-Users & Region - Trends & Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. According to estimates by the International Agency for...

2014-04-29 20:26:30

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Companion Diagnostics Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_companion_diagnostics_market_2014_2018.html About Companion DiagnosticsCompanion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug...

2014-04-29 12:32:37

SAINT-GENIS-POUILLY, France, April 29, 2014 /PRNewswire/ -- Advanced Accelerator Applications S.A. ("AAA" or "the Company"), an international specialist in Molecular Nuclear Medicine, today announced that Dr Kapil Dhingra has joined the Company Board of Directors as an Independent Non-Executive Director. Stefano Buono, Chief Executive Officer of AAA, commented: "Dr. Dhingra's guidance and perspective on clinical development, regulatory and commercial strategy will be...

2014-04-29 08:37:59

With SoftLayer, Healthcare Providers Can Better Analyze and Store Genetic Data in the Cloud to Improve Care LAS VEGAS, April 29, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced a collaboration with Coriell Life Sciences, a provider of genetic analysis at point of care, and CareKinesis, Inc., a Medication Risk Mitigation® pharmacy services firm, to bring personalized medicine to the elderly based on analyzing and storing genetic data in a secure cloud environment....

2014-04-28 20:22:06

Richard Sherman, Swedish donors support new program that combines genomic medicine, supportive care SEATTLE, April 28, 2014 /PRNewswire/ -- The Swedish Cancer Institute (SCI) today announced its new Personalized Medicine Program that combines advanced medical treatments based on the unique, molecular signature of a patient's cancer with supportive care that is designed to serve each individual's physical and emotional health. "Patients diagnosed with cancer often find themselves...

2014-04-28 08:33:27

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lwbs3b/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a...

2014-04-25 23:05:55

This research report categorizes the proteomics market inton instrumentation technologies, reagents, services types, and geography. http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html (PRWEB) April 25, 2014 The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018", analyzes...

2014-04-23 23:04:09

New research report “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” worked out by Kelly Scientific Publications is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 To date, more than 32 million people worldwide are living with cancer. The most frequently occurred types of cancer include breast,...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'